FR2482861A1 - Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal - Google Patents

Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal Download PDF

Info

Publication number
FR2482861A1
FR2482861A1 FR8110140A FR8110140A FR2482861A1 FR 2482861 A1 FR2482861 A1 FR 2482861A1 FR 8110140 A FR8110140 A FR 8110140A FR 8110140 A FR8110140 A FR 8110140A FR 2482861 A1 FR2482861 A1 FR 2482861A1
Authority
FR
France
Prior art keywords
asn
peptide
lys
arg
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8110140A
Other languages
English (en)
French (fr)
Other versions
FR2482861B1 (enExample
Inventor
Noboru Yanaihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2482861A1 publication Critical patent/FR2482861A1/fr
Application granted granted Critical
Publication of FR2482861B1 publication Critical patent/FR2482861B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/822—Identified hapten
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8110140A 1980-05-21 1981-05-21 Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal Granted FR2482861A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6804080A JPS56163456A (en) 1980-05-21 1980-05-21 Preparation of antigen

Publications (2)

Publication Number Publication Date
FR2482861A1 true FR2482861A1 (fr) 1981-11-27
FR2482861B1 FR2482861B1 (enExample) 1983-09-09

Family

ID=13362282

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8110140A Granted FR2482861A1 (fr) 1980-05-21 1981-05-21 Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal

Country Status (8)

Country Link
US (1) US4407965A (enExample)
JP (1) JPS56163456A (enExample)
BE (1) BE888906A (enExample)
DE (1) DE3120312C2 (enExample)
DK (1) DK159163C (enExample)
FR (1) FR2482861A1 (enExample)
GB (1) GB2079289B (enExample)
SE (1) SE454301B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572800A (en) * 1982-09-30 1986-02-25 Otsuka Pharmaceutical Co., Ltd. Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5116725A (en) * 1984-08-08 1992-05-26 Scripps Clinic And Research Foundation Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides
JPS62500452A (ja) * 1984-09-19 1987-02-26 ザ　リ−ジエンツ　オブ　ザ　ユニバ−シテイ　オブ　カリフオルニア ヒト細胞形質転換に関連するレトロウイルスポリペプチド
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
JPH0792458B2 (ja) * 1986-03-14 1995-10-09 郁男 山科 糖鎖特異抗体アツセイプレ−ト及びその製造方法
US5202270A (en) * 1986-05-15 1993-04-13 Abbott Laboratories Cocaine and cocaine metabolites assay tracers, immunogens and antibodies
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
MX2017003535A (es) 2014-09-16 2017-10-27 Regeneron Pharma Anticuerpos anti-glucagon y sus usos.
KR102708864B1 (ko) 2016-08-30 2024-09-25 리제너론 파마슈티칼스 인코포레이티드 글루카곤 수용체 신호전달을 간섭함에 의한 중증 인슐린 저항성의 치료 방법
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
JP7781519B2 (ja) 2017-08-22 2025-12-08 リジェネロン・ファーマシューティカルズ・インコーポレイテッド グルカゴン受容体シグナル伝達に干渉することによって尿素サイクル異常症を治療する方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2380296A1 (fr) * 1977-02-10 1978-09-08 Otsuka Pharma Co Ltd Procede pour preparer un antigene et un anticorps

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206199A (en) * 1977-07-22 1980-06-03 Takeda Chemical Industries, Ltd. Novel glucagon fragment and its derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2380296A1 (fr) * 1977-02-10 1978-09-08 Otsuka Pharma Co Ltd Procede pour preparer un antigene et un anticorps

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1978 *
CA1980 *

Also Published As

Publication number Publication date
DE3120312A1 (de) 1982-03-04
DK159163B (da) 1990-09-10
DK222081A (da) 1981-11-22
BE888906A (fr) 1981-11-23
JPS6223822B2 (enExample) 1987-05-25
DE3120312C2 (de) 1985-08-29
DK159163C (da) 1991-02-11
US4407965A (en) 1983-10-04
FR2482861B1 (enExample) 1983-09-09
GB2079289A (en) 1982-01-20
JPS56163456A (en) 1981-12-16
GB2079289B (en) 1983-10-26
SE8103198L (sv) 1981-11-22
SE454301B (sv) 1988-04-18

Similar Documents

Publication Publication Date Title
US4423034A (en) Process for the preparation of antibodies
EP0093652B1 (fr) Toxine synthétique ST, son procédé de préparation et son application comme agent vaccinant
FR2482861A1 (fr) Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal
FR2503145A1 (fr) Peptides apparentes aux interferons humains, anticorps obtenus a partir de ces peptides et adsorbants obtenus a partir de ces anticorps
EP0232693A2 (fr) Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2521553A1 (fr) Glycine 8-calcitonine
GB2062644A (en) Glucagon fragment and utility hereof
CA2382035C (fr) Composes synthetiques portant deux epitopes pour immunodosages
EP0569309B2 (fr) Polypeptides de synthèse appartenant au virus de l'hépatite C (VHC) et utilisables notamment pour détecter ce dernier
JP3055063B2 (ja) 抗体精製法に有用なヒト絨毛性性腺刺激ホルモン（ｈＣＧ）ペプチド
JP4120846B2 (ja) 活性化ペプチド類および接合体
FR2497198A1 (fr) Peptide pour le dosage de l'hormone parathyroide humaine
FR2756827A1 (fr) Composes synthetiques biepitopiques utilisables comme etalons dans les dosages biologiques de la troponine i
Nachtmann et al. Oxytocin
JP4258271B2 (ja) ポリアミノ酸担体
EP0785432B1 (fr) Procédé pour l'identification ou le dosage immunologique d'antigènes polypeptidiques
FR2737209A1 (fr) Peptide capable d'etre reconnu par des anticorps reconnaissant l'antigene c33 du virus de l'hepatite c
FR2470113A1 (fr) Derives de c-peptides de proinsuline tyrosylee et leur utilisation pour la determination des niveaux de c-peptide de proinsuline dans le serum humain
FR2521554A1 (fr) Des-asparagine-3-calcitonine
JPH0453880B2 (enExample)
JPS6341425B2 (enExample)
JP3419746B2 (ja) エンドセリン−３前駆体に対するモノクローナル抗体およびその用途
FR2601020A1 (fr) Sorbine purifiee, nouveaux peptides ayant des sequences peptidiques en commun avec la sorbine et compositions pharmaceutiques les contenant
FR2458539A1 (fr) Peptides apparentes a la somatostatine, leur preparation et leur utilisation therapeutique
JPH0160780B2 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse